Abeona Therapeutics Inc. (ABEO)

Abeona Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	169	124	53	34	155	167
Market Cap Growth	297.13%	134.61%	54.02%	-77.80%	-7.52%	-51.14%
Enterprise Value	129	77	8	-7	68	46
PE Ratio	-	-2.29	-1.22	-0.40	-1.84	-2.19
PS Ratio	48.22	35.46	37.41	11.45	15.47	-
PB Ratio	-22.33	8.37	1.98	0.81	1.51	0.94
P/FCF Ratio	-4.90	-3.34	-1.26	-0.49	-4.25	-2.42
P/OCF Ratio	-4.98	-3.35	-1.22	-0.52	-4.42	-2.66
EV/Sales Ratio	36.93	21.99	5.69	-2.40	6.84	-
EV/EBITDA Ratio	-2.19	-1.52	-0.23	0.09	-0.92	-0.68
EV/EBIT Ratio	-2.11	-1.43	-0.21	0.09	-0.85	-0.61
EV/FCF Ratio	-3.93	-2.07	-0.19	0.10	-1.88	-0.66
Debt / Equity Ratio	-2.61	0.36	0.29	0.22	0.09	0.04
Debt / EBITDA Ratio	-0.32	-0.11	-0.22	-0.12	-0.12	-0.12
Debt / FCF Ratio	-0.57	-0.15	-0.18	-0.13	-0.24	-0.12
Quick Ratio	5.46	4.10	6.77	3.24	2.26	3.34
Current Ratio	5.61	4.15	6.83	3.39	2.33	3.42
Asset Turnover	0.05	0.06	0.03	0.03	0.06	0
Interest Coverage	-59.41	-128.64	-52.93	-22.23	-19.47	-189.70
Return on Equity (ROE)	-821.50%	-333.70%	-185.60%	-113.00%	-71.50%	-61.10%
Return on Assets (ROA)	-118.60%	-91.50%	-85.70%	-72.20%	-51.80%	-44.10%
Return on Capital (ROIC)	-334.70%	-225.11%	-146.75%	-173.61%	-73.17%	-41.36%
Earnings Yield	-45.42%	-43.66%	-82.19%	-247.29%	-54.45%	-45.60%
FCF Yield	-23.96%	-29.92%	-79.16%	-203.27%	-23.50%	-41.33%
Buyback Yield / Dilution	-61.59%	-171.96%	-99.65%	-6.24%	-84.02%	-5.95%
Total Shareholder Return	-61.59%	-171.96%	-99.65%	-6.24%	-84.02%	-5.95%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).